Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction
- PMID: 4035619
- PMCID: PMC460125
- DOI: 10.1136/thx.40.7.526
Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction
Abstract
Total plasma and mixed stimulated saliva theophylline concentrations (by high performance liquid chromatography) and free plasma theophylline concentrations (by equilibrium dialysis) were measured in simultaneously collected samples from 32 outpatients receiving chronic oral theophylline treatment, who had received the drug at least two hours before sampling. There was a close relationship between saliva and total plasma theophylline concentration and between total saliva and free plasma concentration. The mean saliva to total plasma drug concentration ratio was 0.69 (SE 0.09) and the mean difference between paired saliva and free plasma concentration was 0.65 (0.17) microgram/ml. It is concluded that stimulated mixed saliva provides a simple, non-invasive method of assessing total (and free) plasma theophylline concentrations during chronic oral treatment. The therapeutic range for saliva, corresponding to the generally accepted total plasma concentration range (10-20 micrograms/ml), is approximately 7-14 micrograms/ml.
Similar articles
-
Free and total plasma theophylline concentrations in chronic airflow obstruction.Thorax. 1984 May;39(5):352-5. doi: 10.1136/thx.39.5.352. Thorax. 1984. PMID: 6740537 Free PMC article.
-
Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.Br J Clin Pharmacol. 1984 Jan;17(1):9-14. doi: 10.1111/j.1365-2125.1984.tb04991.x. Br J Clin Pharmacol. 1984. PMID: 6691893 Free PMC article.
-
The disposition of theophylline in blood in chronic obstructive lung disease.Ther Drug Monit. 1986;8(4):424-6. doi: 10.1097/00007691-198612000-00008. Ther Drug Monit. 1986. PMID: 3824427
-
Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease.J Allergy Clin Immunol. 1977 Dec;60(6):335-8. doi: 10.1016/0091-6749(77)90063-x. J Allergy Clin Immunol. 1977. PMID: 925259
-
[Determination of drugs in the saliva].Pharm Unserer Zeit. 1982 Mar;11(2):41-7. doi: 10.1002/pauz.19820110202. Pharm Unserer Zeit. 1982. PMID: 7045889 Review. German. No abstract available.
Cited by
-
Therapeutic drug monitoring in saliva. An update.Clin Pharmacokinet. 1992 Nov;23(5):365-79. doi: 10.2165/00003088-199223050-00003. Clin Pharmacokinet. 1992. PMID: 1478004 Review.
-
Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.Br J Clin Pharmacol. 1992 Jun;33(6):653-6. doi: 10.1111/j.1365-2125.1992.tb04096.x. Br J Clin Pharmacol. 1992. PMID: 1389939 Free PMC article.
-
Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.Br J Clin Pharmacol. 1986 Oct;22(4):383-7. doi: 10.1111/j.1365-2125.1986.tb02906.x. Br J Clin Pharmacol. 1986. PMID: 3768254 Free PMC article.
-
A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.Br J Clin Pharmacol. 2018 Jun;84(6):1089-1108. doi: 10.1111/bcp.13553. Epub 2018 Mar 25. Br J Clin Pharmacol. 2018. PMID: 29442362 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources